Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Vistagen Therapeutics (VTGN) over the last 11 years, with Q4 2025 value amounting to 0.01.

  • Vistagen Therapeutics' Asset Utilization Ratio rose 5852.32% to 0.01 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.01, marking a year-over-year increase of 5852.32%. This contributed to the annual value of 0.0 for FY2025, which is 6821.38% down from last year.
  • Latest data reveals that Vistagen Therapeutics reported Asset Utilization Ratio of 0.01 as of Q4 2025, which was up 5852.32% from 0.01 recorded in Q3 2025.
  • Vistagen Therapeutics' 5-year Asset Utilization Ratio high stood at 0.08 for Q2 2023, and its period low was 0.01 during Q1 2025.
  • For the 5-year period, Vistagen Therapeutics' Asset Utilization Ratio averaged around 0.02, with its median value being 0.01 (2023).
  • Per our database at Business Quant, Vistagen Therapeutics' Asset Utilization Ratio skyrocketed by 40230.73% in 2023 and then tumbled by 8992.15% in 2024.
  • Quarter analysis of 5 years shows Vistagen Therapeutics' Asset Utilization Ratio stood at 0.02 in 2021, then soared by 155.19% to 0.04 in 2022, then crashed by 68.94% to 0.01 in 2023, then plummeted by 45.59% to 0.01 in 2024, then skyrocketed by 58.52% to 0.01 in 2025.
  • Its Asset Utilization Ratio was 0.01 in Q4 2025, compared to 0.01 in Q3 2025 and 0.01 in Q2 2025.